Ligand validation:5IU7

OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLB is a Ligand Of Interest in 5IU7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IU7_OLB_A_2427	24%	51%	0.169	0.842	0.93	0.96	1	1	1	0	76%	0.76
5IU7_OLB_A_2426	24%	53%	0.195	0.843	0.84	0.97	1	1	0	0	88%	0.88
5IU7_OLB_A_2430	15%	45%	0.217	0.825	0.88	1.25	1	1	0	0	76%	0.76
5IU7_OLB_A_2425	14%	52%	0.15	0.763	0.98	0.88	1	1	2	0	64%	0.64
5IU7_OLB_A_2424	7%	53%	0.203	0.689	0.97	0.87	1	1	0	0	76%	0.76
5IU7_OLB_A_2428	6%	56%	0.256	0.682	0.8	0.91	2	1	2	0	100%	1
5IU7_OLB_A_2429	4%	52%	0.302	0.716	0.89	0.97	1	1	1	0	80%	0.8
5IUB_OLB_A_2421	34%	53%	0.166	0.898	0.93	0.89	2	1	0	0	72%	0.72
5IUA_OLB_A_2424	30%	53%	0.17	0.874	0.91	0.92	2	1	0	0	76%	0.76
5IU4_OLB_A_2427	25%	47%	0.193	0.871	0.88	1.17	1	1	0	0	76%	0.76
5NM2_OLB_A_1218	21%	42%	0.261	0.917	1.04	1.2	2	1	0	0	76%	0.7068
5IU8_OLB_A_2427	19%	55%	0.216	0.842	0.87	0.86	2	1	1	0	84%	0.84
4KPP_OLB_A_502	41%	46%	0.17	0.892	1.07	1.02	2	1	0	0	96%	0.96
5LX9_OLB_A_409	37%	93%	0.177	0.876	0.19	0.3	-	-	1	0	100%	0.64
6XLP_OLB_A_616	34%	61%	0.182	0.908	0.8	0.69	-	-	1	0	76%	0.76
7AVN_OLB_B_314	34%	39%	0.105	0.863	1.2	1.18	1	1	3	0	56%	0.56
6BMM_OLB_A_404	33%	53%	0.18	0.857	0.8	1	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.